Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1986 Nov 1;164(5):1626–1640. doi: 10.1084/jem.164.5.1626

Immunity in human schistosomiasis mansoni. Regulation of protective immune mechanisms by IgM blocking antibodies

PMCID: PMC2188460  PMID: 2430044

Abstract

After the demonstration of blocking antibodies during rat experimental schistosomiasis, the existence of such factors was investigated in human schistosomiasis. The depletion, in sera from S. mansoni-infected patients, of a given isotype (IgM) either by protein A-Sepharose (PAS) absorption or by fast protein liquid chromatography (FPLC) induced a significant increase in IgG-mediated killing of S. mansoni schistosomula by human eosinophils. Inhibition experiments showed that IgM-enriched fractions (PAS effluents) were able to inhibit eosinophil- dependent cytotoxicity mediated by IgG fractions (total sera or PAS eluates). Both IgG and IgM antibodies from infected human sera immunoprecipitated antigens of 30,000-40,000 Mr in the labeled detergent extracts of schistosomulum surface. The specificity of IgG and IgM for the 38,000 Mr antigen was suggested by competition experiments using two radiolabeled mAbs (IPLSm1, IPLSm3) directed against this antigen. Moreover, crossinhibition between IgG and IgM antibodies for the Mr 38,000 antigen could be directly demonstrated. The in vivo relevance of such IgM blocking antibodies in the context of human immunity to schistosomiasis was evaluated in two groups of children classified as resistant or susceptible to posttreatment reinfection. IgM antibodies specifically directed against the 38,000 Mr antigen were measured by a capture assay. The mean levels of IgM antibodies were significantly higher in the susceptible than in the resistant group both before and after treatment. These results are consistent with the idea that immunity to schistosomiasis could be attributable not only to the existence of antibodies with defined effector function, but also to the absence of blocking antibodies. The description of the existence in human schistosomiasis of antibody isotypes blocking the effector response against defined surface targets might lead to a new understanding of the mechanisms regulating immunity to reinfection against schistosomes and possibly other parasites.

Full Text

The Full Text of this article is available as a PDF (939.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auriault C., Damonneville M., Verwaerde C., Pierce R., Joseph M., Capron M., Capron A. Rat IgE directed against schistosomula-released products is cytotoxic for Schistosoma mansoni schistosomula in vitro. Eur J Immunol. 1984 Feb;14(2):132–138. doi: 10.1002/eji.1830140206. [DOI] [PubMed] [Google Scholar]
  2. Butterworth A. E., Capron M., Cordingley J. S., Dalton P. R., Dunne D. W., Kariuki H. C., Kimani G., Koech D., Mugambi M., Ouma J. H. Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses. Trans R Soc Trop Med Hyg. 1985;79(3):393–408. doi: 10.1016/0035-9203(85)90391-8. [DOI] [PubMed] [Google Scholar]
  3. Butterworth A. E., Dalton P. R., Dunne D. W., Mugambi M., Ouma J. H., Richardson B. A., Siongok T. K., Sturrock R. F. Immunity after treatment of human schistosomiasis mansoni. I. Study design, pretreatment observations and the results of treatment. Trans R Soc Trop Med Hyg. 1984;78(1):108–123. doi: 10.1016/0035-9203(84)90190-1. [DOI] [PubMed] [Google Scholar]
  4. Butterworth A. E., Remold H. G., Houba V., David J. R., Franks D., David P. H., Sturrock R. F. Antibody-dependent eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: mediation by IgG, and inhibition by antigen-antibody complexes. J Immunol. 1977 Jun;118(6):2230–2236. [PubMed] [Google Scholar]
  5. Butterworth A. E., Sturrock R. F., Houba V., Mahmoud A. A., Sher A., Rees P. H. Eosinophils as mediators of antibody-dependent damage to schistosomula. Nature. 1975 Aug 28;256(5520):727–729. doi: 10.1038/256727a0. [DOI] [PubMed] [Google Scholar]
  6. Butterworth A. E., Taylor D. W., Veith M. C., Vadas M. A., Dessein A., Sturrock R. F., Wells E. Studies on the mechanisms of immunity in human schistosomiasis. Immunol Rev. 1982;61:5–39. doi: 10.1111/j.1600-065x.1982.tb00372.x. [DOI] [PubMed] [Google Scholar]
  7. Capron A., Dessaint J. P., Capron M., Joseph M., Torpier G. Effector mechanisms of immunity to schistosomes and their regulation. Immunol Rev. 1982;61:41–66. doi: 10.1111/j.1600-065x.1982.tb00373.x. [DOI] [PubMed] [Google Scholar]
  8. Capron M., Bazin H., Joseph M., Capron A. Evidence for IgE-dependent cytotoxicity by rat eosinophils. J Immunol. 1981 May;126(5):1764–1768. [PubMed] [Google Scholar]
  9. Capron M., Capron A., Torpier G., Bazin H., Bout D., Joseph M. Eosinophil-dependent cytotoxicity in rat schistosomiasis. Involvement of IgG2a antibody and role of mast cells. Eur J Immunol. 1978 Feb;8(2):127–133. doi: 10.1002/eji.1830080211. [DOI] [PubMed] [Google Scholar]
  10. Capron M., Spiegelberg H. L., Prin L., Bennich H., Butterworth A. E., Pierce R. J., Ouaissi M. A., Capron A. Role of IgE receptors in effector function of human eosinophils. J Immunol. 1984 Jan;132(1):462–468. [PubMed] [Google Scholar]
  11. Capron M., Torpier G., Capron A. In vitro killing of S. mansoni schistosomula by eosinophils from infected rats: role of cytophilic antibodies. J Immunol. 1979 Nov;123(5):2220–2230. [PubMed] [Google Scholar]
  12. Cesbron J. Y., Capron A., Ovlaque G., Santoro F. Use of a monoclonal antibody in a double-sandwich ELISA for detection of IgM antibodies to Toxoplasma gondii major surface protein (P30). J Immunol Methods. 1985 Oct 24;83(1):151–158. doi: 10.1016/0022-1759(85)90068-7. [DOI] [PubMed] [Google Scholar]
  13. Clegg J. A., Smithers S. R. The effects of immune rhesus monkey serum on schistosomula of Schistosoma mansoni during cultivation in vitro. Int J Parasitol. 1972 Mar;2(1):79–98. doi: 10.1016/0020-7519(72)90036-7. [DOI] [PubMed] [Google Scholar]
  14. Dissous C., Dissous C., Capron A. Isolation and characterization of surface antigens from Schistosoma mansoni schistosomula. Mol Biochem Parasitol. 1981 Aug;3(4):215–225. doi: 10.1016/0166-6851(81)90053-0. [DOI] [PubMed] [Google Scholar]
  15. Dissous C., Grzych J. M., Capron A. Biochemical studies on the 30-40 kDa Schistosoma mansoni surface antigens. Mol Biochem Parasitol. 1985 Sep;16(3):277–288. doi: 10.1016/0166-6851(85)90070-2. [DOI] [PubMed] [Google Scholar]
  16. Grzych J. M., Capron M., Bazin H., Capron A. In vitro and in vivo effector function of rat IgG2a monoclonal anti-S. mansoni antibodies. J Immunol. 1982 Dec;129(6):2739–2743. [PubMed] [Google Scholar]
  17. Grzych J. M., Capron M., Dissous C., Capron A. Blocking activity of rat monoclonal antibodies in experimental schistosomiasis. J Immunol. 1984 Aug;133(2):998–1004. [PubMed] [Google Scholar]
  18. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  19. Hofstetter M., Poindexter R. W., Ruiz-Tiben E., Ottesen E. A. Modulation of the host response in human schistosomiasis. III. Blocking antibodies specifically inhibit immediate hypersensitivity responses to parasite antigens. Immunology. 1982 Aug;46(4):777–785. [PMC free article] [PubMed] [Google Scholar]
  20. Joseph M., Auriault C., Capron A., Vorng H., Viens P. A new function for platelets: IgE-dependent killing of schistosomes. Nature. 1983 Jun 30;303(5920):810–812. doi: 10.1038/303810a0. [DOI] [PubMed] [Google Scholar]
  21. Khalife J., Capron M., Grzych J. M., Bazin H., Capron A. Fc gamma receptors on rat eosinophils: isotype-dependent cell activation. J Immunol. 1985 Oct;135(4):2780–2784. [PubMed] [Google Scholar]
  22. Marchalonis J. J., Cone R. E., Santer V. Enzymic iodination. A probe for accessible surface proteins of normal and neoplastic lymphocytes. Biochem J. 1971 Oct;124(5):921–927. doi: 10.1042/bj1240921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mathew G. D., Qualtiere L. F., Neel H. B., 3rd, Pearson G. R. IgA antibody, antibody-dependent cellular cytotoxicity and prognosis in patients with nasopharyngeal carcinoma. Int J Cancer. 1981 Feb 15;27(2):175–180. doi: 10.1002/ijc.2910270208. [DOI] [PubMed] [Google Scholar]
  24. Sampson I. A., Hodgen A. N., Arthur I. H. The separation of immunoglobulin M from human serum by fast protein liquid chromatography. J Immunol Methods. 1984 Apr 13;69(1):9–15. doi: 10.1016/0022-1759(84)90271-0. [DOI] [PubMed] [Google Scholar]
  25. Steele G., Jr, Ankerst J., Sjögren H. O., Vang J., Lannerstad O. Absorption of blocking activity from human tumor-bearer sera by Staphylococcus aureus, Cowan I. Int J Cancer. 1975 Feb 15;15(2):180–189. doi: 10.1002/ijc.2910150203. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES